Fasting: Clinical Trials

75 trials for Fasting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

75 completed. 75 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 175Completed 75
Phase 22Completed 2

Follow Fasting: new trials by email Literature Review of Fasting trials Research Report on Fasting

Trials (filtered) newest first · largest first

All 75 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers
Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg - Healthy, Fasting
Phase 1CompletedLG Chem282026-06-112026-09-10
A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.
balcinrenone/ dapagliflozin, quinidine - Healthy Participants
Phase 1CompletedAstraZeneca142025-05-202025-08-12
In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)
Dexmethylphenidate - Healthy Volunteers in Fed and Fasted State
Phase 1CompletedCingulate Therapeutics252024-10-312025-08-12
Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions
Lamotrigine 100 MG - Fasting
Phase 1CompletedDesitin Arzneimittel GmbH242023-04-032024-01-10
Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects
Dexmethylphenidate - Healthy Volunteers in Fed and Fasted State
Phase 1CompletedCingulate Therapeutics272022-09-142022-10-20
Bioequivalence Study of Rivaroxaban 2.5 mg Tablets Under Fasting and Fed Conditions
Rivaroxaban 2.5 mg Test Tablet, Rivaroxaban 2.5 mg Reference Tablet - Healthy Participants
Phase 1CompletedThe Affiliated Hospital of Qingdao University642022-03-162026-09-08
Intermittent Fasting and CLL/SLL
Intermittent fast - Neoplasms, Leukemia, Lymphocytic, Chronic
Phase 1CompletedEleah Stringer152021-02-032023-02-14
Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting
Esomeprazole, Placebo - Dyspepsia
Phase 1 / Phase 2CompletedUniversity of Monastir5002020-01-202025-02-25
A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects
Perindopril tert-Butylamine tablets ( Produced by Haisco), Perindopril tert-Butylamine tablets(ACERTIL®) - Healthy
Phase 1CompletedSichuan Haisco Pharmaceutical Group Co., Ltd322018-11-292020-09-21
Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects
Bosentan 125 mg, Tracleer 125Mg Tablet - Bioequivalence
Phase 1CompletedGeropharm642018-05-242019-09-24
Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions
Metformine, Glucophage® Long, Metformin - Bioequivalence
Phase 1CompletedGeropharm282017-06-152018-07-03
Bioequivalence Study of Metformin 1000 mg Tablets Immediate Release (IR) Versus Glucophage® 1000 mg Tablets IR In Healthy Subjects
Metformin, Glucophage® - Bioequivalence
Phase 1CompletedGeropharm182017-02-142018-07-03
To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers
RP6530 - Healthy
Phase 1CompletedRhizen Pharmaceuticals SA182016-02-012017-11-28
Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects
Dutasteride-Test product, Dutasteride-Reference product - Prostatic Hyperplasia
Phase 1CompletedGlaxoSmithKline362015-09-092018-06-19
Bioequivalence Study of Sorafenib Tablet and Nexavar
Nexavar, Sorafenib - Fasting
Phase 1CompletedYabao Pharmaceutical Group362015-07-012015-11-06
Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions
Candesartan Cilexetil in formulation 1, Candesartan Cilexetil in formulation 2, ATACAND - Cardiovascular Disease
Phase 1CompletedGlaxoSmithKline182014-12-022018-03-12
A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions
Eltrombopag - Cirrhosis, Liver
Phase 1CompletedGlaxoSmithKline262014-08-282017-11-13
AStudy to Evaluate the Bioavailability of PF 04965842 in Healthy Subjects
PF-04965842, PF- 04965842 - Healthy
Phase 1CompletedPfizer122014-06-012014-08-18
Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
Levodopa Carbidopa immediate release tablets - Fasted State
Phase 1CompletedDesitin Arzneimittel GmbH122014-03-012014-04-17
Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue
Meal, Exercise, Sestamibi - Molecular Imaging
Phase 1CompletedMayo Clinic1542013-09-012017-04-18

Showing 20 of 75. Sign in to see all of them.

Narrower conditions

Lecithin Cholesterol Acyltransferase Deficiency (9)  ·  Cardiovascular Diseases (1)  ·  Dyspepsia (1)  ·  Feeding Behavior (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Intermittent Fasting (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Liver Cirrhosis (1)  ·  Motor Activity (1)  ·  Neoplasms (1)  ·  Prostatic Hyperplasia (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Behavior (75)  ·  Feeding Behavior (74)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Dyslipidemias (9)  ·  Genetic Diseases, Inborn (9)  ·  Hypoalphalipoproteinemias (9)  ·  Hypolipoproteinemias (9)  ·  Lipid Metabolism Disorders (9)  ·  Lipid Metabolism, Inborn Errors (9)  ·  Metabolic Diseases (9)  ·  Metabolism, Inborn Errors (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Pathologic Processes (3)  ·  Chronic Disease (2)

Interventions

Doxycycline (3)  ·  Lisinopril (3)  ·  Metformin (3)  ·  Ondansetron (3)  ·  Clonazepam (2)  ·  Clopidogrel (2)  ·  Dexmethylphenidate Hydrochloride (2)  ·  Dronabinol (2)  ·  Etodolac (2)  ·  Hydrochlorothiazide (2)  ·  Metoprolol (2)  ·  Olanzapine (2)  ·  Tablets (2)  ·  dapagliflozin (2)  ·  recombinant methionyl human leptin (2)

Sponsors

Par Pharmaceutical, Inc. (18)  ·  Dr. Reddy's Laboratories Limited (12)  ·  IPCA Laboratories Ltd. (12)  ·  AstraZeneca (3)  ·  Geropharm (3)  ·  GlaxoSmithKline (3)  ·  Beth Israel Deaconess Medical Center (2)  ·  Cingulate Therapeutics (2)  ·  Desitin Arzneimittel GmbH (2)  ·  Mutual Pharmaceutical Company, Inc. (2)  ·  Actavis Inc. (1)  ·  Eleah Stringer (1)  ·  INSYS Therapeutics Inc (1)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (1)  ·  LG Chem (1)

Countries

India (20)  ·  United States (16)  ·  Canada (14)  ·  Russia (3)  ·  United Kingdom (3)  ·  China (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Germany (1)  ·  Indonesia (1)  ·  Ireland (1)  ·  Japan (1)  ·  Jordan (1)  ·  Mexico (1)  ·  Thailand (1)

Top investigators

Dr. Hardik Dave, M.B.B.S (4)  ·  Eric Masson, Pharm.D. (3)  ·  Anthony R Godfrey, Pharm.D. (2)  ·  Christian Aumais (2)  ·  Dr. Hardik Dave, M.B.B.S. (2)  ·  Gary Shillito (2)  ·  Matt Brams, MD (2)  ·  Ali Ziaee (1)  ·  Antonio Pizzaro (1)  ·  Antonio R. Pizarro, M.D., (1)  ·  Benoit Girard, M.D. (1)  ·  Christian Sicard, M.D (1)  ·  Christos S Mantzoros, MD DSc FACP FACE (1)  ·  Christos S Mantzoros, MD, DSc (1)

Results publications

PMID 21917874, PMID 33051459, PMID 35820631, PMID 18201934, PMID 20703446, PMID 21045179, PMID 21660636, PMID 22775199, PMID 23193213, PMID 23713767, PMID 25540981, PMID 25613340, PMID 29856004, PMID 30479286, PMID 35061234, PMID 39097160, PMID 41120363

NIH funding

M01RR001032 (1), R01DK058785 (1), R44CA143716 (1)